ArticleScientific reports2026
Targeting NLRP3 with GDC-2394 ameliorates airway inflammation and smooth muscle hyperplasia in experimental asthma by suppressing the IL-6/JAK2/STAT3 axis.
Zhiyuan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.